Discontinuation studies confirm that visceral fat begins to re-accumulate within weeks of stopping treatment, typically returning toward baseline within 612 months
By accelerating recovery, reducing downtime from injuries, and enhancing overall physical function, athletes can maintain peak performance and reduce the likelihood of recurrent injuries
The STEP 1 clinical trial showed Wegovy leads to an average weight loss of around 15% after 68 weeks, making it one of the most effective weight-loss medications available
If youre interested in increasing your healthspan to extend your lifespan, Dr
Their effects on appetite suppression, glycaemic control and sustained weight reduction are well established in large-scale clinical trials
(9) Elena M Khvatova, Victor N Samartzev, Pavel P Zagoskin, Igor A Prudchenko, and Inessa I Mikhaleva (2003) Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia Peptides, 2003 Feb, Volume 24 (Issue 2), Pages 307-11
